NRS is a market leading and award winning provider of products and services designed to support independent living.

The Leicestershire-based company’s products and services help people with mobility issues to be self-sufficient within the home to either delay or prevent more expensive residential or acute care, and speed up departure from such environments.

In 2013 LDC backed the acquisition of NRS Healthcare, the healthcare division of Findel plc for a gross consideration of £24million.

Since the original investment, LDC supported the transformation of the business' model to become a full service provider of domiciliary care and home adjustment equipment and services, alongside significant organic growth and infrastructure investment.

Revenues at NRS Healthcare increased 46% from £90million (2013) to £132million (2014), the business also increased its staff by a third from 553 (2013) to 734 (2014) employees.

In 2014 LDC partially exited NRS Healthcare after the business secured investment from H2 Equity Partners. On realisation, LDC has achieved a 2.8x return on money invested and will retain a minority investment in the business going forward.

LDC are looking forward to continue their backing for the business and help the management team drive forward the evolution and scaling of the business.

In October 2016 NRS Healthcare  were ranked 208th in the Sunday Times Grant Thornton Top Track 250 league table. The league table is a ranking of Britain's private mid-market growth companies with the biggest sales.